Overall, our study results are in agreement with the existing literature, where emerging evidence indicates that the presence of CD206- and CD274-positive monocytes in the liver metastatic site of CRC patients correlates with aggressive disease progression and unfavorable clinical outcomes. This evidence concerns the gene CD274 and colorectal carcinoma.